Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays 
OpenAI Explores Massive Funding Round at $750 Billion Valuation 
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies 
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
MOORESTOWN, N.J., Aug. 29, 2017 -- Tabula Rasa HealthCare Corporation (NASDAQ:TRHC), a healthcare technology company disrupting the field of medication safety, announces that the largest Program of All-Inclusive Care for the Elderly organization (PACE) has signed an agreement for medication risk management services with CareKinesis, its wholly owned subsidiary focused on PACE. CenterLight Healthcare PACE selected TRHC to work with the Interdisciplinary Care Team (IDT) to streamline workflows and improve outcomes for participants. The agreement will begin with a launch center with additional locations to be added over time in consideration of specific clinical, economic, and satisfaction-related outcomes.
CenterLight Healthcare’s PACE Organization is a vanguard of the community physician model that enables patients to keep their primary care physician once they enroll in PACE. This model is now enabled through a waiver program. CMS is considering eliminating the waiver in its newly proposed conditions of participation to increase access to PACE. TRHC will collaborate with CenterLight network and employed prescribers and staff to reduce hospital admissions, re-admissions and total costs while increasing participant and provider satisfaction.
“We have been exploring options for a medication risk partner,” said CenterLight Chief Medical Officer, Dr. Thomas. “It has been a pleasure to learn about Tabula Rasa’s unique Medication Risk Mitigation® software and Medication Decision Support and Adherence tools that personalize each participant’s medication regimen. We look forward to improving quality and outcomes for our PACE participants.”
“TRHC continues to advance the practice and science of medication risk mitigation through our personalized medicine approach,” said Chairman and CEO Calvin H. Knowlton, PhD. “We are pleased to have formalized this collaboration with CenterLight with the goal of optimizing outcomes for their participants by reducing the risk of adverse drug events while improving adherence.”
The Agreement takes effect September 1, 2017.
About CenterLight Healthcare PACE
CenterLight Healthcare is an innovative managed care organizations that excels in providing long-term healthcare services throughout the Bronx, Kings (Brooklyn), New York (Manhattan), Queens, Richmond (Staten Island), Nassau, Suffolk and Westchester counties. CenterLight’s goal is to help clients enjoy the highest possible quality of life while living safely in their own homes and communities.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Since 2011, TRHC, through its wholly-owned subsidiary, CareKinesis, has focused on optimizing outcomes for PACE and other healthcare organizations using its unique Medication Risk Mitigation software and Medication Decision Support and Adherence tools that personalize each participants medication regimen. For more information, please visit: www.TRHC.com.
Contact: Media TRHC Dianne Semingson [email protected] T: 215-870-0829
